Lilly, Novo Nordisk Under Government Investigation For Promotion Of Their Diabetes Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
The Attorney General of Texas is looking into Lilly's marketing of Actos while the Massachusetts U.S. Attorney's Office is investigating Novo's promotion of NovoLog, Levemir and Victoza.
You may also be interested in...
Novo Probe By U.S. Expands To Insulin Manufacturing
Massachusetts U.S. Attorney’s office, which is also investigating firm’s marketing, now subpoenas Novo Nordisk for documents relating to potential issues at its plant in Kalundborg, Denmark.